Wells Fargo Cuts Ventas (VTR) Price Target to $96

Wells Fargo kept an Overweight rating on Ventas, Inc. (NYSE:VTR) while lowering its price target to $96.0 from $104.0 on October 19, 2026. The research note provides a forward-looking perspective on the healthcare real estate investment trust as analysts across Wall Street adjust their outlooks ahead of upcoming financial results.

VTR Ventas, Inc.

$84.86 ▲ +11.76% year to date

1M 3M YTD

Daily close · Oct 19, 2026

Wells Fargo's Call on Ventas

On October 19, 2026, Wells Fargo maintained its Overweight stance on Ventas, trimming the price target to $96.0 from $104.0 previously. Earlier, on September 1, 2026, the same firm had kept an Overweight rating with a $104.0 price target. The updated target sits below several other recent Wall Street estimates, reflecting shifting views on the healthcare facility operator.

Other Institutional Activity in Ventas

Principal Financial Group, Inc. reduced its holdings by 1,364,763 shares, ending with 13,969,657 shares worth about $1,185,395,291.0 in its report filed for the period ending June 30, 2026. Meanwhile, Apg Asset Management US Inc. held its position steady with 11,314,857 shares valued at roughly $960,122,228.0.

Ventas, Inc. Stock Holds Steady

Ventas shares recently traded around $85.86 as of October 19, 2026, sitting up about 1.2% from an event close of $84.86 on that same date. The stock trades below its 50-day moving average of $88.33 and just under its 200-day moving average of $86.10. Over the past year, the equity has ranged from a low of $68.15 to a high of $101.60.

Recent Earnings

Ventas pulled in trailing twelve-month revenue of $6.42 billion alongside earnings of $0.54 per share. Profitability metrics show a net profit margin of 4.1% and a return on equity of 2.0%. Investors look ahead to the company's next earnings report, which is scheduled for October 27, 2026.

Dividend

The real estate investment trust pays an annual dividend rate of $2.08 per share, translating to a dividend yield of 2.42%. The payout ratio stands at 370.4% based on recent trailing results.

Insider Buying and Selling at Ventas, Inc.

Corporate insiders have also adjusted their holdings during recent months. Director Walter C. Rakowich sold 1,152 shares on May 14, 2026, at an average price of $90.20 for a total value of $103,915.0. Later, director Michael J. Embler purchased 2,500 shares on June 3, 2026, at $78.81 per share, totaling $197,025.0.

Analysts Set New Price Targets

Wall Street firms continue to update their views on the real estate firm. Scotiabank maintained a Sector Perform rating with a $95.0 target on September 2, 2026. Evercore ISI Group kept an Outperform rating while adjusting its target to $100.0 on September 21, 2026. Barclays maintained an Equal-Weight rating with a $91.0 target on October 13, 2026. Consensus analyst opinion currently leans toward a buy recommendation with a mean price target of $100.50 across 22 total analyst reviews.

About Ventas

Ventas, Inc. is a real estate investment trust centered on healthcare and senior housing properties across North America and the United Kingdom. The company owns about 1,450 properties, with a heavy focus on senior living communities that serve an aging demographic. Its operations play a key role in providing specialized environments for older adults.

Bottom Line

Wells Fargo's decision to lower its target to $96.0 places new focus on how the firm evaluates the stock's near-term potential. Market participants will watch the upcoming earnings release on October 27, 2026, for fresh signals on property operations and financial health.